Archived Facts

Human Genome Sciences Inc. and GlaxoSmithKline PLC said Friday that the Food and Drug Administration wants three more months before making a decision on their lupus drug candidate Benlysta, delaying the agency’s decision until around March 10.
All News, Video and Posts related to SECTOR: Health Care

Popular Posts:

Related Posts:

Leave a Reply